CBDAfrica.com Editorial Policy

Effective date: 25.09.2026
Last reviewed: 25.09.2026
Applies to: All content published on CBDAfrica.com and its associated platforms

1. Purpose of the Editorial Policy

This Editorial Policy sets the standards by which CBDAfrica.com researches, creates, reviews, publishes, updates, corrects and manages all content. It exists to ensure that the information we provide is accurate, useful, transparent and responsible.

CBDAfrica.com aims to become a trusted information and industry resource for the African CBD, hemp and cannabis sectors. Readers turn to us for reliable guidance on policy, cultivation, processing, products, research, business opportunities and regulatory developments across the continent. Inaccurate or poorly sourced information in this field can mislead consumers, harm businesses, or create unrealistic expectations about health outcomes. We therefore treat accuracy and clarity as non-negotiable.

We clearly distinguish between different types of content:

Journalism and news – independent reporting of facts and developments.
Educational and explanatory content – guides, explainers and country overviews intended to inform.
Industry and business information – reports, directories, profiles and market data.
Commercial content – sponsored articles, advertorials, paid listings and advertisements (always labelled).
User-generated or submitted content – directory entries, event listings and contributions that are reviewed but not fully independently verified in every case.

Editorial independence is fundamental. Commercial relationships do not dictate what we cover or how we cover it. This policy applies to every form of content published on CBDAfrica.com, including articles, news, country guides, educational resources, medical cannabis and CBD information, hemp and farming content, industry reports, business profiles, company listings, product-related information, events, conferences, webinars, interviews, opinion pieces, guest contributions, sponsored content, advertisements, press releases, user-submitted directory entries, and social media content where the site’s standards apply.

2. Our Editorial Principles

Accuracy
We verify facts before publication. Claims about regulation, science, markets or products must be supported by reliable sources. We prefer primary sources and correct errors promptly when they occur.

Independence
Editorial decisions are made by the editorial team. Advertisers, sponsors, listed companies, product manufacturers, event organisers, PR agencies, governments or political organisations do not determine what we publish or the conclusions we reach.

Transparency
We disclose sponsorships, affiliations, conflicts of interest and the nature of commercial content. Sources are cited or linked where appropriate. Readers should be able to understand the basis for the information presented.

Fairness
We present issues in context, avoid sensationalism, and give relevant parties a fair opportunity to respond when criticism is involved. We do not allow personal or commercial agendas to distort coverage.

Evidence-based reporting
Especially on scientific, medical and regulatory topics, we prioritise established evidence over speculation. We distinguish between preliminary findings, animal or laboratory studies, and human clinical evidence.

Responsible publishing
We recognise that cannabis, CBD and hemp remain highly regulated and sensitive subjects across African jurisdictions. We avoid promoting illegal activity, exaggerated health claims, or content that could reasonably be interpreted as medical advice.

Respect for readers
We write clearly, avoid unnecessary jargon, and respect the diversity of African contexts, languages and regulatory environments. Content is intended to inform, not to alarm or oversell.

Clear attribution
Facts, data, quotes and opinions are attributed. We do not present others’ work or claims as our own without credit.

Separation of editorial and commercial interests
Editorial content and commercial content are distinct. Payment for advertising, sponsorship, directory placement or affiliate relationships does not purchase favourable editorial coverage.

Correction of errors
When we get something wrong, we correct it visibly and promptly.

Regular updating
Regulatory, scientific and market information changes. We review and update key pages, especially country guides and educational resources, on a planned basis.

African relevance and context
We prioritise African sources, African regulatory frameworks, African research and African industry developments. Global information is included only when it has clear relevance to the continent.

3. Editorial Independence

Editorial decisions at CBDAfrica.com are not improperly influenced by advertisers, sponsors, affiliate partners, listed businesses, product manufacturers, CBD or cannabis companies, event organisers, PR agencies, government bodies, political organisations or commercial partners.

We may work with commercial partners in the following ways while preserving independence:

Accepting advertising and sponsorship that is clearly labelled.
Offering paid directory listings and business profiles that are factually checked but not editorially endorsed beyond the stated information.
Publishing sponsored content or advertorials that are explicitly marked as such.
Covering industry events, including those organised by partners, on their merits.

Payment, advertising, sponsorship or directory placement does not guarantee favourable editorial coverage, preferential placement of news, or suppression of critical information. Editorial staff retain final control over headlines, framing, sourcing and conclusions in non-sponsored content.

Any attempt to pressure editorial staff to alter coverage in exchange for commercial benefit will be reported internally and resisted. Staff with personal or financial conflicts related to a story must declare them and, where necessary, recuse themselves from related decisions.

4. Sources and Research Standards

Writers and editors follow a clear hierarchy of preferred sources:

Government departments, national regulators and official gazettes
African national and regional authorities (AU bodies, regional economic communities, national cannabis/hemp authorities)
Universities and academic institutions
Peer-reviewed scientific research
International organisations (WHO, UNODC, FAO, etc.) where relevant
Established medical and scientific organisations
Recognised industry associations
Independent recognised experts with verifiable credentials
Reputable news organisations with strong fact-checking records
Company information and press releases (treated as primary source for the company’s own claims, not as independent verification)
User-submitted information (subject to review and clear labelling where verification is limited)

Primary sources are preferred over secondary sources whenever possible. Important claims — especially those concerning regulation, legality, health effects, market size or product claims — must be verified against at least one reliable source, and preferably more than one for significant assertions.

Sources should be linked or clearly cited so readers can examine the original material. When a source cannot be linked (e.g., a private interview or offline document), the nature of the source should still be described. Anonymous sources are used sparingly and only when the information is important, the source is credible, and there is a legitimate reason for anonymity.

Writers must not rely solely on company marketing materials, unverified social media claims, or secondary summaries when primary documentation is available.

5. Scientific and Medical Content

Because CBDAfrica.com covers CBD, hemp, medical cannabis and related health topics, higher standards apply to scientific and medical information.

All medical and health-related information must be evidence-based.
Health claims must not be exaggerated. We do not present CBD, cannabis or related products as cures or guaranteed treatments.
Writers must distinguish established evidence from emerging or preliminary research.
Preliminary research, preprints, animal studies or laboratory findings must not be presented as established medical fact or proof of human clinical effectiveness.
Correlation must not be presented as causation.
Medical claims should be attributed to credible, named sources.
Readers are always encouraged to consult qualified healthcare professionals for personal medical advice. Content on CBDAfrica.com is for information and education only and does not constitute medical advice, diagnosis or treatment recommendations.

Where African clinical data or regulatory guidance exists, it is prioritised. Where it does not, we clearly note the limitations of available evidence and avoid extrapolating findings from other regions without context.

We do not publish content that makes unsubstantiated therapeutic claims or that could reasonably be read as encouraging self-medication in place of professional care.

6. Content Creation, Review and Approval

All original editorial content goes through a defined process:

Research and drafting by a writer or contributor.
Fact-checking of key claims, especially regulatory, scientific and statistical assertions.
Editorial review for accuracy, clarity, fairness, tone and compliance with this policy.
Final approval by an editor before publication.

Guest contributions, opinion pieces and interviews are reviewed for factual accuracy and policy compliance; opinions remain those of the author and are clearly labelled. Press releases may be published or adapted but are treated as company statements unless independently verified.

7. Corrections, Updates and Retractions

When a factual error is identified, we correct it as soon as practicable. Significant corrections are noted on the page with the date of the correction. Minor typos that do not affect meaning may be corrected without a formal note.

Key educational pages, country guides and regulatory summaries are reviewed periodically and updated when material changes occur. Outdated information that could mislead is either updated or clearly marked as historical.

In rare cases of serious error that cannot be adequately corrected by amendment, content may be retracted with an explanation.

8. Sponsored Content, Advertising and Commercial Relationships

All sponsored content, advertorials and paid placements are clearly labelled as such (e.g., “Sponsored”, “Advertisement”, “Partner Content”). Editorial content is never presented as independent when it is paid for or directed by a commercial partner.

Directory listings and business profiles are commercial products. Inclusion does not constitute an endorsement of the business, its products or its claims. We reserve the right to reject or remove listings that contain false, misleading or illegal claims.

Affiliate links, where used, are disclosed.

9. User-Submitted and Directory Content

User-submitted directory entries, event listings and similar contributions are reviewed for basic accuracy and compliance before publication. CBDAfrica.com does not independently verify every claim made by submitters. Users remain responsible for the accuracy of information they provide. We may edit, refuse or remove submissions that violate this policy or applicable law.

10. Conflicts of Interest

Editorial staff and regular contributors must declare any financial, personal or professional interests that could reasonably be seen to influence their work on a given topic. Declared conflicts are managed by the editorial team and, where necessary, disclosed to readers or result in reassignment of the story.

11. Legal and Regulatory Compliance

Content must comply with applicable laws in the jurisdictions where it is published and where it is primarily consumed. We do not publish content that promotes illegal cultivation, sale or use of controlled substances. We take particular care with claims that could be interpreted as medical advice or product claims under consumer-protection or medicines regulations.

This policy does not create legal obligations beyond those already imposed by law, but it guides our internal standards.

12. Feedback and Concerns

Readers who identify errors, have concerns about accuracy, independence or potential conflicts, or wish to request a correction may contact the editorial team at editorial@cbdafrica.com. Legitimate concerns are investigated and addressed in line with this policy.

This Editorial Policy is a living document. It will be reviewed periodically and updated as the African cannabis, hemp and CBD sectors, and the standards of responsible digital publishing, evolve.

CBDAfrica.com Editorial Team